Physician profile
James Monroe Wright
NPI 1417391012
$7,531.41
in general payments reported to CMS, 2019-2025
9 companies · $448 in 2025
The $448 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.66 · 2020: $486 · 2021: $5,185 · 2022: $39.13 · 2023: $35.00 · 2024: $1,322 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,210 · Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,210.00 |
| Food and Beverage | $594.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,338.25 | 2020-2022 | |
| Medical Device Business Services, INC. | $2,298.93 | 2021-2024 | Viper |
| Globus Medical, INC. | $1,057.47 | 2021 | |
| Depuy Synthes Sales INC. | $554.44 | 2021-2025 | Trialtis, Symphony, Sentio |
| Medtronic, INC. | $139.13 | 2021-2025 | Inceptiv |
| Nuvasive, INC. | $70.78 | 2020 | |
| Implanet America, INC. | $35.20 | 2025 | |
| Si-Bone, INC. | $20.55 | 2020 | |
| Csl Behring | $16.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.